Determining Bioequivalency in
Similar Bipharmaceuticals

A continuing medical education activity sponsored by NAMCP and AAMCN
This activity was held live at the 2007 Fall Managed Care Forum.

This activity is valid from February 28, 2008 to March 1, 2009.

 

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This activity is supported by an educational grant from Allergan

PLEASE CLICK HERE TO VIEW PRESENTATION


PLEASE CLICK HERE FOR POST TEST AND EVALUATION

Instructions for CME/CEU:  View the presentation, answer the post test, complete the evaluation form and submit to keads@namcp.org.  You will have the option on the post test/evaluation page to submit your forms electronically or by faxing them to Katie Eads at 804-747-5316.

Summary
Protein biologicals are complex pharmaceutical drugs produced by and purified from living organisms. Medical institutions, government agencies and private sector third party payers are currently faced with a variety of issues about the relative properties and merits of different biological products, particularly products with similar mechanisms of actions. This presentation will provide methods of determining equivalency in comparing similar biopharmaceuticals.

Objectives

  • Describe the basic pharmacology and clinical applications of botulinum toxins
     
  • Describe the Summary of Product Characteristics document and its usefulness as a source comparison of different pharmaceutical products

  • Describe the similarities and difference of two commercial botulinum toxin type A products and understand the ramifications on payers and providers

Faculty: Richard Wenzel, PharmD, Pharmacist, Diamond Headache Clinic Inpatient Unit
   

Disclosure:

Dr. Wenzel serves as a consultant to GlaxoSmithKline and on the speakers bureau for Allergan and Ortho McNeil. NAMCP CME committee determined this did not present a conflict of interest in regards to the content of his presentation.

 

Accreditation & Designation

The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. NAMCP designates this activity for a maximum of 1 AMA PRA Category I creditsTM. Each physician should claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses (AAMCN) has been approved as a provider of continuing education by the Virginia Nurses Association (VNA) VNA is accredited as an approver of continuing education in nursing by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses who complete this activity will be awarded 1.0 contact hours.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.

  

This activity is supported by an educational grant from Allergan